Avedro Inc

Avedro Inc (AVDR) priced its initial public offering on Feb 14, 2019 at $14.00 per share, within its $14.00–$16.00 range, raising $70M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $238.8M. J.P. Morgan was lead-left underwriter, joined by TD Cowen, Guggenheim and Leerink Partners. Cooley advised the company and Latham & Watkins advised the underwriters.

Avedro, Inc. is a commercial-stage ophthalmic medical technology company treating corneal ectatic disorders and reducing dependence on eyeglasses or contact lenses. Its Corneal Remodeling Platform pairs KXL and Mosaic UVA light systems with single-use riboflavin formulations to perform corneal cross-linking.

Status

IPO

Ticker

AVDR

Exchange

Nasdaq Global Market

Priced

Feb 14, 2019

IPO price

$14.00

Price range

$14.00–$16.00

Raised

$70M

Market cap at IPO price

$238.8M

First filed

Jan 18, 2019

Underwriters

J.P. Morgan, TD Cowen, Guggenheim and Leerink Partners

Company counsel

Cooley

Underwriters' counsel

Latham & Watkins

Sector

Biotech & pharma

Country / state

MA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.